The healthcare start-up TeleClinic has completed a Series A financing round in which the French financial investor Idinvest Partners has invested in the company.<\/p>\n\n
The Munich-based company TeleClinic offers remote medical treatment by cooperating doctors and is the first company in Germany to receive approval for exclusive remote medical treatment. The TeleClinic doctors are allowed to make diagnoses and treat patients via the Internet – primarily by video consultation. TeleClinic GmbH is also the only provider in Germany to offer a functional e-prescription including the necessary digital doctor’s signature. <\/p>\n\n
Idinvest Partners is a Paris-based investment company specializing in the SME segment and active throughout Europe with total assets under management of over EUR 6 billion. Idinvest Partners’ investment focus is on innovative companies with high growth potential. <\/p>\n\n
Renzenbrink & Partner advised TeleClinic GmbH comprehensively on all aspects of the financing round. The law firm has outstanding expertise in advising on venture capital transactions, both on the corporate and investor side. The Renzenbrink & Partner team consisted of partners Dr. Dennis Schlottmann<\/a> and Dr. Ulf Renzenbrink<\/a> (both Corporate\/Venture Capital) as well as associate Dr. Alexander Haunschild<\/a> (Corporate\/Venture Capital). <\/p>\n\n <\/p>\n","protected":false},"featured_media":1468,"template":"","class_list":["post-1567","deals","type-deals","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n